Abstract
ISPOR 16th Annual European Meeting; Dublin, Ireland; November 2 – 6, 2013 Patients’ and Caregivers’ Preferences for Bone Metastases Treatments in the United States Y Qian,1 A Mohamed,2 AB Hauber,2 H Collins,3 G Hechmati,4 F Gatta,4 J Arellano1 1Global Health Economics, Amgen Inc., Thousand Oaks, CA, United States; 2RTI Health Solutions, Research Triangle Park, NC, United States; 3Clinical Development, Amgen Inc., Thousand Oaks, CA, United States; 4Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
